Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...
Researchers have long considered the Stuxnet attacks on Iran's nuclear centrifuges in Natanz to be the opening chapter of ...
Defender’s advantage for territory denial: drones alter the ratio of force required to overcome an entrenched defender.
Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a major global health threat that acts as the primary vector for several severe ...
Turkey’s trajectory is not dependent on the outcome of the Iranian case - it is a function of its desire to claim leadership ...
Zilliz, the creator of Milvus — the world's most widely adopted open-source vector database with over 43,000 GitHub stars and ...
As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni ...
With oil prices in mind, the Trump administration has deployed a haphazard approach to sanctions on Russia and Iran.
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results